Series B - CytoReason
Investment Firm
Overview
CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.
Announced Date
Jul 17, 2024
Closed on Date
Jul 17, 2024
Funding Type
Series B
Highlights
N/A
Location
N/A
Social
N/A
Investor Lead
N/A
Participant Investors
4
| Investor Name |
|---|
 NVIDIA |
Round Details and Background
CytoReason raised $80000000 on 2024-07-17 in Series B
CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 09, 2021 | 1 | - | undefined | |
| Jan 04, 2022 | 1 | - | undefined | |
| Sep 20, 2022 | 1 | - | 20.0M | |
| Jul 17, 2024 | 4 | - | 80.0M |
Recent Activity
There is no recent news or activity for this profile.